AI must be framed as a force multiplier, not as a substitute
The real opportunity with AI in clinical trials? More human oversight.
AI can automate tasks. But human judgment, context and accountability remain essential.
For clinical development, the AI opportunity is in reduced routine work and digital driven insights so people can focus their efforts where it matters most. That means designing AI around people and keeping them firmly in the lead.
But realizing that potential takes more than introducing new technology. Organizations also need to rethink how work gets done, drawing a clear line between the tasks suited to automation and the decisions that require human judgment. Done thoughtfully, this approach can help create more capacity for strategic decision-making, trial oversight and cross-functional alignment.
When people understand that AI is there to support their judgment rather than replace it, organizations can create stronger conditions for adoption. Clear accountability, explainable outputs and human oversight can help keep people at the center as AI becomes more integrated into everyday work.
Discover why Troy Bryenton, Vice President of Clinical Platforms at Fortrea, believes AI should be approached as a force multiplier for human experience and knowledge, not a substitute for it.
Discover more about Fortrea Intelligent Technology™ and how AI can help sponsors and sites run smarter, more connect clinical trials.